Provided by Tiger Fintech (Singapore) Pte. Ltd.

Theravance Biopharma

10.69
+0.07500.71%
Volume:58.68K
Turnover:621.50K
Market Cap:534.26M
PE:-9.01
High:10.71
Open:10.51
Low:10.46
Close:10.61
Loading ...
Aug 25, 2022

Major Issues Report

8-K - Current report
Aug 08, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2022

Correspondence

CORRESP [Cover] - Correspondence
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 20, 2022

Major Issues Report

8-K - Current report
Jul 14, 2022

Major Issues Report

8-K - Current report
Jul 13, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
May 06, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2022

Major Issues Report

8-K - Current report
Apr 28, 2022

Major Issues Report

8-K - Current report
Apr 21, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 04, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals